Some studies reported that promoter methylation of the p16, CDH1, RUNX3, MLH1, RASSF1A, p15, APC, DAPK, GSTP1, Reprimo, and MGMT was frequent in the blood in patients with GC [34–38]. Here, RASSF1 is linked to gastric cancer.